Celldex Therapeutics Shares Down 26.0% Since SmarTrend's Sell Call (CLDX) By: Comtex SmarTrend® News Briefs April 01, 2014 at 11:11 AM EDT Read More >> Related Stocks: Celldex Therapeutics